1. Home
  2. SANM vs MDGL Comparison

SANM vs MDGL Comparison

Compare SANM & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanmina Corporation

SANM

Sanmina Corporation

HOLD

Current Price

$218.55

Market Cap

13.3B

Sector

Technology

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$508.79

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANM
MDGL
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
12.8B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
SANM
MDGL
Price
$218.55
$508.79
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
$155.00
★ $674.45
AVG Volume (30 Days)
★ 479.0K
187.6K
Earning Date
04-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.07
N/A
EPS
★ 4.71
N/A
Revenue
★ $7,890,475,000.00
$180,133,000.00
Revenue This Year
$74.61
$58.39
Revenue Next Year
$13.43
$48.55
P/E Ratio
$46.91
★ N/A
Revenue Growth
★ 16.78
N/A
52 Week Low
$113.71
$393.61
52 Week High
$288.68
$615.00

Technical Indicators

Market Signals
Indicator
SANM
MDGL
Relative Strength Index (RSI) 59.62 41.57
Support Level $213.47 $501.27
Resistance Level $230.56 $546.29
Average True Range (ATR) 9.85 16.42
MACD 2.52 -2.55
Stochastic Oscillator 73.07 18.73

Price Performance

Historical Comparison
SANM
MDGL

About SANM Sanmina Corporation

Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: